Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.

@article{Wang2000ChineseTO,
  title={Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.},
  author={J. George Wang and Jan A Staessen and Lan-sheng Gong and Lisheng Liu},
  journal={Archives of internal medicine},
  year={2000},
  volume={160 2},
  pages={211-20}
}
BACKGROUND In 1988, the Systolic Hypertension in China (Syst-China) Collaborative Group initiated the placebo-controlled Syst-China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension. OBJECTIVES To explore (1) whether the benefits of active treatment were evenly distributed across 4 strata, prospectively defined according to sex and previous cardiovascular… CONTINUE READING

8 Figures & Tables

Connections & Topics

Mentioned Connections BETA
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
Male sex , previous cardiovascular complications , older age , higher systolic BP or lower diastolic BP , living in northern China , smoking , and diabetes mellitus significantly and independently increased the risk of 1 or more of the following end points : total or cardiovascular mortality , all fatal and nonfatal cardiovascular end points , all strokes , and all cardiac end points .
Male sex , previous cardiovascular complications , older age , higher systolic BP or lower diastolic BP , living in northern China , smoking , and diabetes mellitus significantly and independently increased the risk of 1 or more of the following end points : total or cardiovascular mortality , all fatal and nonfatal cardiovascular end points , all strokes , and all cardiac end points .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In elderly Chinese patients with isolated systolic hypertension , stepwise antihypertensive drug treatment , starting with the dihydropyridine calcium channel blocker nitrendipine , improved prognosis .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
In 1988 , the Systolic Hypertension in China ( Syst - China ) Collaborative Group initiated the placebo - controlled Syst - China trial to investigate whether antihypertensive drug treatment could reduce the incidence of fatal and nonfatal stroke in older Chinese patients with isolated systolic hypertension .
All Topics